The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Pandya, Anant Kumar
    Pharmacist born in October 1956
    Individual (5 offsprings)
    Officer
    2013-12-11 ~ now
    OF - Director → CIF 0
    Mr Anant Kumar Pandya
    Born in October 1956
    Individual (5 offsprings)
    Person with significant control
    2024-05-23 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Chan, Ma-wai Joshua
    Pharmaceutical Scientist born in December 1964
    Individual (3 offsprings)
    Officer
    2013-12-11 ~ now
    OF - Director → CIF 0
    Mr Ma-wai Joshua Chan
    Born in December 1964
    Individual (3 offsprings)
    Person with significant control
    2024-05-23 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 3
    Speirs, Christopher James, Dr
    Doctor born in June 1947
    Individual (2 offsprings)
    Officer
    2013-12-11 ~ now
    OF - Director → CIF 0
    Dr Christopher James Speirs
    Born in June 1947
    Individual (2 offsprings)
    Person with significant control
    2024-05-23 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

SYNERGY PHARMA CONSULTING LIMITED

Previous name
SYNERGY PHARMA LIMITED - 2013-12-13
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Called-up share capital not yet paid and not classified as a current asset
300 GBP2024-04-30
300 GBP2023-04-30
Current Assets
389,244 GBP2024-04-30
331,987 GBP2023-04-30
Creditors
Amounts falling due within one year
-33,720 GBP2024-04-30
-26,227 GBP2023-04-30
Net Current Assets/Liabilities
355,524 GBP2024-04-30
305,760 GBP2023-04-30
Total Assets Less Current Liabilities
355,824 GBP2024-04-30
306,060 GBP2023-04-30
Net Assets/Liabilities
355,824 GBP2024-04-30
306,060 GBP2023-04-30
Equity
355,824 GBP2024-04-30
306,060 GBP2023-04-30
Average Number of Employees
02023-05-01 ~ 2024-04-30
02022-05-01 ~ 2023-04-30

  • SYNERGY PHARMA CONSULTING LIMITED
    Info
    SYNERGY PHARMA LIMITED - 2013-12-13
    Registered number 08810551
    20-22 Wenlock Road, London N1 7GU
    Private Limited Company incorporated on 2013-12-11 (11 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-12-11
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.